GXP-PHARMA SUPPORT ApS: Financial statements 2017
CVR: 36033347
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
GXP-PHARMA SUPPORT ApS (CVR 36033347) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,084,666 and a net result of DKK 423,986 compared with DKK 153,689 the year before. That is a decrease of 25.2% compared with the year before. Equity in the 2017 report amounted to DKK 1,871,667. The solvency ratio was 58.8%.
- Gross Profit
- DKK 1,084,666
- Profit/Loss
- DKK 423,986
- Equity
- DKK 1,871,667
- Total Assets
- DKK 3,183,458
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.1 mio. | 424 t. | 1.9 mio. | - |
| 2016 | - | 1.5 mio. | 154 t. | 1.4 mio. | - |
Keep an eye on GXP-PHARMA SUPPORT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
GXP-PHARMA SUPPORT ApS has published its annual report for 2016. Gross profit came to DKK 1,450,436, and the net result was DKK 153,689.
About GXP-PHARMA SUPPORT ApS
GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.